LT3710446T - Junginiai, naudingi cdk7 slopinimui - Google Patents

Junginiai, naudingi cdk7 slopinimui

Info

Publication number
LT3710446T
LT3710446T LTEPPCT/US2018/060025T LTUS2018060025T LT3710446T LT 3710446 T LT3710446 T LT 3710446T LT US2018060025 T LTUS2018060025 T LT US2018060025T LT 3710446 T LT3710446 T LT 3710446T
Authority
LT
Lithuania
Prior art keywords
cdk7
inhibition
compounds useful
compounds
useful
Prior art date
Application number
LTEPPCT/US2018/060025T
Other languages
English (en)
Inventor
David Andrew Coates
Carlos Montero
Bharvin Kumar Rameschandra Patel
David Michael Remick
Vipin Yadav
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of LT3710446T publication Critical patent/LT3710446T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/US2018/060025T 2017-11-16 2018-11-09 Junginiai, naudingi cdk7 slopinimui LT3710446T (lt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17382778 2017-11-16
EP18382034 2018-01-23
EP18382546 2018-07-20
PCT/US2018/060025 WO2019099298A1 (en) 2017-11-16 2018-11-09 Compounds useful for inhibiting cdk7

Publications (1)

Publication Number Publication Date
LT3710446T true LT3710446T (lt) 2022-09-26

Family

ID=64477309

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2018/060025T LT3710446T (lt) 2017-11-16 2018-11-09 Junginiai, naudingi cdk7 slopinimui

Country Status (33)

Country Link
US (3) US10472370B2 (lt)
EP (1) EP3710446B1 (lt)
JP (1) JP6633254B2 (lt)
KR (1) KR102450727B1 (lt)
CN (1) CN111344292B (lt)
AU (1) AU2018369508B2 (lt)
BR (1) BR112020008253A2 (lt)
CA (1) CA3080910C (lt)
CL (1) CL2020001218A1 (lt)
CR (1) CR20200184A (lt)
DK (1) DK3710446T3 (lt)
DO (1) DOP2020000102A (lt)
EC (1) ECSP20025899A (lt)
ES (1) ES2925219T3 (lt)
HR (1) HRP20221152T1 (lt)
HU (1) HUE060078T2 (lt)
IL (1) IL274540B (lt)
JO (1) JOP20200122B1 (lt)
LT (1) LT3710446T (lt)
MD (1) MD3710446T2 (lt)
MX (1) MX2020004932A (lt)
MY (1) MY197700A (lt)
NZ (1) NZ763551A (lt)
PE (1) PE20210392A1 (lt)
PH (1) PH12020550792A1 (lt)
PL (1) PL3710446T3 (lt)
RS (1) RS63530B1 (lt)
SA (1) SA520411990B1 (lt)
SG (1) SG11202003677UA (lt)
SI (1) SI3710446T1 (lt)
TW (1) TWI703149B (lt)
UA (1) UA122893C2 (lt)
WO (1) WO2019099298A1 (lt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10336760B2 (en) * 2014-04-05 2019-07-02 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (CDK7)
TWI703149B (zh) * 2017-11-16 2020-09-01 美商美國禮來大藥廠 用於抑制cdk7之化合物
WO2021087138A1 (en) * 2019-10-29 2021-05-06 Syros Pharmaceuticals, Inc. Methods of treating cancer in biomarker-identified patients with inhibitors of cyclin-dependent kinase 7 (cdk7)
WO2021121390A1 (zh) 2019-12-20 2021-06-24 苏州信诺维医药科技股份有限公司 杂环化合物及其药物组合物、制备方法、中间体和应用
CN114075205A (zh) * 2020-08-12 2022-02-22 隆泰申医药科技(南京)有限公司 Cdk激酶抑制剂、其制备方法、药物组合物和应用
USD987844S1 (en) 2021-08-31 2023-05-30 MerchSource, LLC Percussion massager
USD1078077S1 (en) 2021-08-31 2025-06-03 MerchSource, LLC Percussion massager
USD1079043S1 (en) 2021-08-31 2025-06-10 MerchSource, LLC Percussion massager
USD1079042S1 (en) 2021-08-31 2025-06-10 MerchSource, LLC Percussion massager
USD1060711S1 (en) 2021-08-31 2025-02-04 MerchSource, LLC Percussion massager
USD1051414S1 (en) 2021-08-31 2024-11-12 MerchSource, LLC Percussion massager
USD1079041S1 (en) 2021-08-31 2025-06-10 MerchSource, LLC Percussion massager
USD1079044S1 (en) 2021-08-31 2025-06-10 MerchSource, LLC Percussion massager
USD1004119S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD1004118S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD1004117S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD994898S1 (en) 2021-11-17 2023-08-08 MerchSource, LLC Percussion massager
USD995812S1 (en) 2021-11-22 2023-08-15 MerchSource, LLC Percussion massager
USD1009292S1 (en) 2021-12-22 2023-12-26 MerchSource, LLC Percussion massager
USD1018881S1 (en) 2021-12-22 2024-03-19 MerchSource, LLC Percussion massager
USD1004121S1 (en) 2021-12-31 2023-11-07 MerchSource, LLC Pivoting percussion massager
USD1004122S1 (en) 2021-12-31 2023-11-07 MerchSource, LLC Pivoting percussion massager
CN114452391B (zh) * 2022-01-28 2023-08-25 深圳市泰尔康生物医药科技有限公司 Cdk16作为靶标在制备用于治疗三阴性乳腺癌的药物中的应用
AU2023370363A1 (en) 2022-10-25 2025-04-24 Tuojie Biotech (Shanghai) Co., Ltd. Piperidinopyrimidine derivative, preparation method therefor and use thereof in medicine
WO2024125532A1 (zh) * 2022-12-12 2024-06-20 杭州德睿智药科技有限公司 作为CDKs抑制剂的新型并杂环类新化合物及其应用
WO2025040170A1 (zh) * 2023-08-24 2025-02-27 杭州德睿智药科技有限公司 作为CDKs抑制剂的新型并杂环类新化合物及其应用
USD1111182S1 (en) 2024-03-19 2026-02-03 MerchSource, LLC Percussion massager
USD1111181S1 (en) 2024-03-19 2026-02-03 MerchSource, LLC Percussion massager

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1701073B (zh) * 2002-09-04 2011-06-22 先灵公司 作为细胞周期蛋白依赖激酶抑制剂的吡唑并[1,5-a]嘧啶
GB201403093D0 (en) * 2014-02-21 2014-04-09 Cancer Rec Tech Ltd Therapeutic compounds and their use
US10336760B2 (en) * 2014-04-05 2019-07-02 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (CDK7)
CA2978170C (en) * 2015-03-09 2024-02-27 Aurigene Discovery Technologies Limited Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
AU2016243529B2 (en) 2015-03-27 2021-03-25 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
EP3302448B1 (en) 2015-06-04 2023-10-25 Aurigene Oncology Limited Substituted heterocyclyl derivatives as cdk inhibitors
EP4019515A1 (en) 2015-09-09 2022-06-29 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
TWI703149B (zh) * 2017-11-16 2020-09-01 美商美國禮來大藥廠 用於抑制cdk7之化合物

Also Published As

Publication number Publication date
WO2019099298A1 (en) 2019-05-23
PL3710446T3 (pl) 2022-10-10
EP3710446A1 (en) 2020-09-23
TWI703149B (zh) 2020-09-01
US10472370B2 (en) 2019-11-12
IL274540B (en) 2022-06-01
CL2020001218A1 (es) 2020-08-21
MY197700A (en) 2023-07-06
PH12020550792A1 (en) 2021-04-12
CN111344292A (zh) 2020-06-26
SA520411990B1 (ar) 2022-07-24
CN111344292B (zh) 2022-06-03
MD3710446T2 (ro) 2022-12-31
CR20200184A (es) 2020-06-01
RS63530B1 (sr) 2022-09-30
US10787460B2 (en) 2020-09-29
AU2018369508B2 (en) 2021-03-11
DK3710446T3 (da) 2022-08-01
US20210032257A1 (en) 2021-02-04
KR102450727B1 (ko) 2022-10-06
EP3710446B1 (en) 2022-07-20
AU2018369508A1 (en) 2020-05-07
SG11202003677UA (en) 2020-05-28
TW201930305A (zh) 2019-08-01
DOP2020000102A (es) 2020-08-31
US20200017513A1 (en) 2020-01-16
SI3710446T1 (sl) 2022-09-30
JOP20200122B1 (ar) 2023-09-17
CA3080910A1 (en) 2019-05-23
IL274540A (en) 2020-06-30
HRP20221152T1 (hr) 2022-11-25
ES2925219T3 (es) 2022-10-14
PE20210392A1 (es) 2021-03-02
MX2020004932A (es) 2020-08-27
BR112020008253A2 (pt) 2020-11-17
CA3080910C (en) 2023-02-07
JP2019537616A (ja) 2019-12-26
JP6633254B2 (ja) 2020-01-22
NZ763551A (en) 2021-12-24
ECSP20025899A (es) 2020-06-30
KR20200070323A (ko) 2020-06-17
JOP20200122A1 (ar) 2020-05-20
HUE060078T2 (hu) 2023-01-28
UA122893C2 (uk) 2021-01-13
US20190144456A1 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
LT3710446T (lt) Junginiai, naudingi cdk7 slopinimui
CY2024003I2 (el) Ενωσεις χρησιμες ως αναστολεις κινασης
IL269216A (en) Macrocyclic compounds as ros1 kinase inhibitors
DK3704120T3 (da) Heterocykliske forbindelser som prmt5-inhibitorer
DK3728252T3 (da) 4-azaindolforbindelser
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
LT3580220T (lt) Aminotriazolopiridinai, kaip kinazės inhibitoriai
PL3209656T3 (pl) Związki indolo-karboksyamidu użyteczne jako inhibitory kinazy
HUE042390T2 (hu) Heteroaril vegyületek kinázgátlásra
LT3371190T (lt) Heterocikliniai junginiai, kaip pi3k-gama inhibitoriai
DK3119762T3 (da) Benzimidazol-derivater som erbb-tyrosin-kinase-inhibitorer til behandlingen af kræft
HRP20200216T1 (hr) Novi metilpiperidinski spojevi, korisni za inhibiranje mikrosomske prostaglandin-e2-sintaze-1
EP3247692A4 (en) INHIBITORS OF TRKA KINASE
DK3724190T3 (da) Substituerede bicykliske heterocykliske forbindelser som PRMT5 inhibitorer
LT3609898T (lt) Junginiai, naudingi kaip ret inhibitoriai
SI3145929T1 (sl) 5-kloro-2-difluorometoksifenil pirazolopirimidinove spojine, ki so zaviralci janusove kinaze
HUE050842T2 (hu) Janus-kináz inhibitor
EP3609871A4 (en) ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS
LT3704118T (lt) Aminoimidazopiridazinai, kaip kinazės inhibitoriai
DK3341379T3 (da) EZH2-hæmmere
EP3684772C0 (en) CYCLIC IMINOPYRIMIDINE DERIVATIVES AS KINASE INHIBITORS
DK4039675T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
HUE049606T2 (hu) Eljárás flavonoid inklúziós vegyületek elõállítására
DK3458460T3 (da) Imidazoler som histondemethylase-inhibitorer
LT3534885T (lt) Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui